Masimo (NASDAQ:MASI) Announces Earnings Results, Beats Expectations By $0.38 EPS

Masimo (NASDAQ:MASI) posted its quarterly earnings data on Tuesday. The medical equipment provider reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.38, Zacks reports. Masimo had a return on equity of 14.98% and a net margin of 3.85%.

Masimo Trading Down 0.7 %

Shares of MASI stock opened at $169.54 on Wednesday. The stock has a market capitalization of $9.08 billion, a price-to-earnings ratio of 116.92 and a beta of 1.02. The company’s fifty day simple moving average is $172.65 and its two-hundred day simple moving average is $152.54. Masimo has a 1 year low of $101.61 and a 1 year high of $184.51. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11.

Analyst Upgrades and Downgrades

MASI has been the subject of several research reports. Stifel Nicolaus restated a “buy” rating and set a $190.00 price target (up previously from $170.00) on shares of Masimo in a research report on Friday, November 22nd. Piper Sandler increased their target price on shares of Masimo from $180.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, December 18th. Wells Fargo & Company lifted their price target on shares of Masimo from $171.00 to $193.00 and gave the stock an “overweight” rating in a report on Wednesday, December 11th. Needham & Company LLC reissued a “hold” rating on shares of Masimo in a report on Wednesday. Finally, Raymond James boosted their target price on Masimo from $170.00 to $194.00 and gave the company an “outperform” rating in a research note on Friday, December 27th. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $191.40.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.